HLA-B27 has no effect on the phenotypic expression of progressive ankylosis in ank/ank mice

H E Krug1, J D Taurog

  • 1Department of Medicine, Department of Veterans Affairs Medical Center, and the University of Minnesota School of Medicine, Minneapolis, USA. krugx002@tc.umn.edu

Abstract

Insights

Human Leukocyte Antigen B27 (HLA-B27) does not influence murine progressive ankylosis (MPA) development in mice. The study suggests distinct disease processes for ankylosis and HLA-B27-associated conditions.

Area of Science:

  • Immunogenetics
  • Rheumatology
  • Mouse Models of Disease

Background:

  • Ankylosing spondylitis is a chronic inflammatory disease.
  • Murine progressive ankylosis (MPA) is a genetic mouse model for ankylosis.
  • The role of Human Leukocyte Antigen B27 (HLA-B27) in ankylosis is not fully understood.

Purpose of the Study:

  • To determine if HLA-B27 influences the expression of murine progressive ankylosis (MPA).
  • To investigate the interaction between HLA-B27 and the ank/ank genotype in a mouse model.

Main Methods:

  • Breeding of HLA-B27 transgenic mice with ank/ank mice.
  • Observation of F1 and F2 progeny phenotypes.
  • Assessment of ankylosis development in relation to B27 status.

Main Results:

  • Mice heterozygous for the ank gene (ank/+) showed no abnormalities.
  • Mice homozygous for the ank gene (ank/ank) exhibited the typical MPA phenotype, regardless of B27 presence.
  • HLA-B27 status did not alter the expression or severity of MPA.

Conclusions:

  • Both HLA-B27 and the ank/ank genotype are independent risk factors for bony ankylosis.
  • The disease processes associated with HLA-B27 and MPA appear distinct and noninteractive.
  • These findings do not support a role for the human homolog of the ank locus in ankylosing spondylitis pathogenesis.